Cargando…

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients

Background: Periodical fecal immunochemical testing (FIT) is a cost-effective strategy in colon cancer screening programmes. FIT is also used as a diagnostic test in symptomatic patients, but data, are scarce. Aim: To determine the association between FIT-Hb concentration and the risk of advanced ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Mercedes, Hijos, Gonzalo, Ramirez, Teresa, Omella, Ignacio, Carrera-Lasfuentes, Patricia, Lanas, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510055/ https://www.ncbi.nlm.nih.gov/pubmed/31131279 http://dx.doi.org/10.3389/fmed.2019.00091

Ejemplares similares

Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020)

The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
por: Domper-Arnal, María José, et al.
Publicado: (2022)

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer
por: Hernandez-Ainsa, Maria, et al.
Publicado: (2022)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic
por: Aznar-Gimeno, Rocío, et al.
Publicado: (2021)

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019
por: Ariño Pérez, Inés, et al.
Publicado: (2022)

Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase
por: Caviglia, Gian Paolo, et al.
Publicado: (2016)

Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy
por: Kawamura, Takuji, et al.
Publicado: (2020)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
por: Lanas, Ángel, et al.
Publicado: (2023)

Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers
por: Lee, Yi-Chia, et al.
Publicado: (2017)

Editorial: Improving the gut microbiome: applications of fecal transplantation in disease
por: García-Mateo, Sandra, et al.
Publicado: (2023)

Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men
por: Kim, Nam Hee, et al.
Publicado: (2017)

The Importance of Symptomatic or Asymptomatic Transcatheter Heart Valve Thrombosis
por: Seropian, Ignacio M.
Publicado: (2021)

Elevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Belobrajdic, D P, et al.
Publicado: (2008)

Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
por: Irún, Pilar, et al.
Publicado: (2023)

Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees
por: Peng, Szu-Min, et al.
Publicado: (2019)

Hemoglobin Charge Dependence on Hemoglobin Concentration in Vitro
por: Gary-Bobo, C. M., et al.
Publicado: (1971)

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2007)

Rapid screening of SARS-CoV-2 infection: Good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals
por: Sicilia, Paola, et al.
Publicado: (2022)

Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals
por: Larsen, Inger K, et al.
Publicado: (2006)

Colorectal cancer population screening programs worldwide in 2016: An update
por: Navarro, Mercedes, et al.
Publicado: (2017)

Prediction of the severity of colorectal lesion by fecal hemoglobin concentration observed during previous test in the French screening program
por: Balamou, Christian, et al.
Publicado: (2021)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
por: Irún, Pilar, et al.
Publicado: (2023)

Synovial Fluid Biomarker Concentrations in Knees with Symptomatic Meniscus Injury Compared to Asymptomatic Contralateral Knees
por: Clair, Andrew, et al.
Publicado: (2019)

Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G
Publicado: (2008)

Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2008)

Asymptomatic and Symptomatic Carotid Stenosis: An Obsolete Classification?
por: Chatzikonstantinou, Anastasios, et al.
Publicado: (2012)

Human rhinovirus infections in symptomatic and asymptomatic subjects
por: Camargo, C.N., et al.
Publicado: (2012)

Asymptomatic and Pre-Symptomatic COVID-19 in China
por: Wu, Zunyou, et al.
Publicado: (2020)

Infectivity of asymptomatic versus symptomatic COVID-19
por: Sayampanathan, Andrew A, et al.
Publicado: (2021)

An algorithm to predict advanced proximal colorectal neoplasia in Chinese asymptomatic population
por: Liwen Huang, Jason, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b27plqhfhvk4bahlkd10d5arq3